Main content

Exploration of Canine Mesenchymal Stromal Cells and Cell Reprogramming for Future Immunotherapy and Cartilage Repair

Show full item record

Title: Exploration of Canine Mesenchymal Stromal Cells and Cell Reprogramming for Future Immunotherapy and Cartilage Repair
Author: Russell, Keith Andrew
Department: Department of Biomedical Sciences
Program: Biomedical Sciences
Advisor: Koch, Thomas Gadegaard
Abstract: There are an estimated 6.4 million dogs living in 34% of Canadian households. Dogs suffer from many conditions where only poor to no treatments exist. For example, cartilage injury, osteoarthritis, and other inflammatory disorders have been inadequately remedied by traditional medical care. Increasing effort has been put toward the innovation and optimization of cell-based therapies for tissue regeneration and immune modulation. Approaches include the use of mesenchymal stromal cells (MSC), induced pluripotent stem cells (iPSC), and other cell engineering techniques such as gene over-expression in somatic cells. The hypothesis was that canine cells with immunomodulatory and chondrogenic properties can be isolated from adipose tissue (AT), bone marrow (BM), or articular cartilage (AC) and utilized to generate canine iPSC. The objectives were: 1) to assess the immunomodulatory and chondrogenic properties of canine AT- and BM-MSC and 2) to generate iPSC from canine MSC or chondrocytes and verify their pluripotency and chondrogenesis. Canine MSC were derived from AT and BM. Isolation success and proliferation rates were compared when using two different culture supplements: fetal bovine serum (FBS) and platelet lysate (PL). Despite the fact that PL is slowly displacing use of the increasingly expensive and xenogeneic FBS in human MSC culture, PL proved detrimental to canine MSC. It did not support isolation or long-term culture of MSC and showed evidence of inducing spontaneous adipogenesis. MSC source was also investigated. Few differences were found pertaining to differentiation and immunomodulation. Both MSC populations have good adipogenic and osteogenic, but poor chondrogenic potential, and have proficient lymphocyte suppressive properties. What distinguished AT- from BM-derived MSC were higher proliferation rates. Since MSC were found to be poorly chondrogenic, both canine MSC and chondrocytes were used to generate iPSC. Some signs of reprogramming were apparent. However, the conditions needed to stabilize reprogrammed cells were not yet identified. In conclusion, AT is the recommended source of canine MSC for immunotherapy. A practical source of chondrogenic cells for canine cartilage engineering strategies has not yet been established, but this work is a promising starting point for further study.
Date: 2017-04
Rights: Attribution-NonCommercial-NoDerivs 2.5 Canada
Terms of Use: All items in the Atrium are protected by copyright with all rights reserved unless otherwise indicated.

Files in this item

Files Size Format View Description
Russell_Keith_201704_PhD.pdf 51.83Mb PDF View/Open Thesis

This item appears in the following Collection(s)

Show full item record

Attribution-NonCommercial-NoDerivs 2.5 Canada Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 2.5 Canada